Understanding a molecule’s product quality attributes (PQAs), including their effect on structure–function relationships and long-term stability, is essential to ensure the safety and efficacy of biotherapeutics.
A multi-attribute method (MAM), based on LC-MS peptide mapping and automation principles, can offer a faster, more efficient method of characterizing and monitoring PQAs than the current plethora of routine chromatographic and electrophoretic assays.
Watch this free webinar to learn how MS-based MAM provides simultaneous detection, identification, quantitation and quality control (monitoring) of PQAs. The webinar covers how a dedicated team at Pfizer developed a multi-site “Lab-of-the-Future” for streamlined MAM analyses.
Duration: 1 hour
Key topics
- Learn how LC-MS peptide mapping using high resolution accurate mass (HRAM) mass spectrometry provides simultaneous detection, identification, quantitation, and quality control (monitoring) of PQAs.
- See how a team of experts in Pfizer has developed a “Lab-of-the-Future” at two of the company’s drug development sites
- Learn how MAM can be used to provide enhanced product understanding along with increased efficiency
Who should attend
- Biopharmaceutical research, development, CMC and QC scientists
- Protein characterization and biologic drug development professionals responsible for quality or manufacturing controls
- Regulatory scientists looking for greater knowledge of this promising methodology
